APA (7th ed.) Citation

Faksová, K., & Laksafoss, A. D. Human papillomavirus nonavalent (HPV9) vaccination and risk of immune mediated diseases, myocarditis, pericarditis, and thromboembolic outcomes in Denmark: Self-controlled case series study. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Faksová, Kristýna, and Anna D. Laksafoss. Human Papillomavirus Nonavalent (HPV9) Vaccination and Risk of Immune Mediated Diseases, Myocarditis, Pericarditis, and Thromboembolic Outcomes in Denmark: Self-controlled Case Series Study. BMJ Publishing Group.

MLA (9th ed.) Citation

Faksová, Kristýna, and Anna D. Laksafoss. Human Papillomavirus Nonavalent (HPV9) Vaccination and Risk of Immune Mediated Diseases, Myocarditis, Pericarditis, and Thromboembolic Outcomes in Denmark: Self-controlled Case Series Study. BMJ Publishing Group.